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Coxiella burnetii, the etiological agent of Q fever in humans, is an intracellular pathogen that replicates in an acidified parasito-
phorous vacuole derived from host lysosomes. Generation of this replicative compartment requires effectors delivered into the
host cell by the Dot/Icm type IVb secretion system. Several effectors crucial for C. burnetii intracellular replication have been
identified, but the host pathways coopted by these essential effectors are poorly defined, and very little is known about how spa-
cious vacuoles are formed andmaintained. Here we demonstrate that the essential type IVb effector, CirA, stimulates GTPase
activity of RhoA. Overexpression of CirA in mammalian cells results in cell rounding and stress fiber disruption, a phenotype
that is rescued by overexpression of wild-type or constitutively active RhoA. Unlike other effector proteins that subvert Rho
GTPases to modulate uptake, CirA is the first effector identified that is dispensable for uptake and instead recruits Rho GTPase
to promote biogenesis of the bacterial vacuole. Collectively our results highlight the importance of CirA in coopting host Rho
GTPases for establishment of Coxiella burnetii infection and virulence in mammalian cell culture and mouse models of
infection.
The naturally obligate intracellular pathogen Coxiella burnetii isthe causative agent of Q fever in humans. The agent’s high
infectivity, ease of spread by aerosols, and environmental stability
have led to its classification as a category B select agent by the
Centers for Disease Control and Prevention (1). The primary
route of infection is through inhalation of contaminated aerosols,
which typical results in acute Q fever, a debilitating flu-like illness
that is generally self-limiting and readily resolves without antibi-
otic treatment. However, under some circumstances, persistent
infection can lead to chronic Q fever that presents as endocarditis
or hepatitis (1). While the number of reported cases of acute Q
fever in the United States has been relatively low, a marked in-
crease occurred in 1999 when Q fever became a reportable disease.
A recent outbreak of Q fever in The Netherlands resulted in over
4,000 confirmed cases, with 20% of patients requiring hospitaliza-
tion (2). The dramatic increase in reported cases suggests C. bur-
netii is an emerging pathogen and highlights our lack of under-
standing of C. burnetii virulence factors.
Inhalation of C. burnetii by a mammalian host results in actin-
dependent endocytosis and internalization in an early endosome.
While numerous intracellular pathogens actively subvert the de-
fault endocytic pathway to establish a unique host-derived vacu-
ole, C. burnetii generally follows the default trafficking pathway to
establish a Coxiella-containing vacuole (CCV) derived from the
host lysosomal network. Generation of this unique replicative
compartment requires active bacterial protein synthesis which
drives homotypic and heterotypic vesicle fusions associated with
generation of a spacious CCV that occupies the majority of the
host cytoplasmic space (3–5). Manipulation of numerous host cell
processes by C. burnetii is required to maintain the CCV and an
intracellular environment essential for growth and replication, in-
cluding inhibition of apoptosis (6), induction of autophagy (4, 7),
recruitment of secretory components (3), and modulation of host
kinases and phosphatases (8, 9) and involves reprograming of the
host transcriptome (10).
Central to pathogenesis is a specialized type IVB secretion sys-
tem (T4SS) that is homologous to the Dot/Icm secretion system of
Legionella pneumophila. In Legionella, this system is composed of
26 dot/icm (defect in organelle trafficking/intracellular multiplica-
tion) genes that together form a pilus-like structure that spans the
bacterial inner and outer membrane to deliver bacterial proteins
into the host cell cytoplasm. Recent advances, including axenic
culture (11) and genetic manipulation (12, 13), have enabled ex-
periments that confirm that, like the Legionella secretion system,
the Dot/Icm system of C. burnetii is essential for intracellular rep-
lication, CCV formation, effector translocation, and modulation
of host apoptosis (14, 15).
Received 21 January 2016 Returned for modification 29 February 2016
Accepted 14 June 2016
Accepted manuscript posted online 20 June 2016
Citation Weber MM, Faris R, van Schaik EJ, McLachlan JT, Wright WU, Tellez A,
Roman VA, Rowin K, Case EDR, Luo Z-Q, Samuel JE. 2016. The type IV secretion
system effector protein CirA stimulates the GTPase activity of RhoA and is
required for virulence in a mouse model of Coxiella burnetii infection. Infect
Immun 84:2524–2533. doi:10.1128/IAI.01554-15.
Editor: C. R. Roy, Yale University School of Medicine
Address correspondence to James E. Samuel, jsamuel@medicine.tamhsc.edu.
* Present address: Mary M. Weber, Laboratory of Bacteriology, NIAID, National
Institutes of Health Rocky Mountain Laboratories, Hamilton, Montana, USA; Robert
Faris, Laboratory of Persistent Viral Diseases, NIAID, National Institutes of Health
Rocky Mountain Laboratories, Hamilton, Montana, USA.
Supplemental material for this article may be found at http://dx.doi.org/10.1128
/IAI.01554-15.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.
crossmark
2524 iai.asm.org September 2016 Volume 84 Number 9Infection and Immunity
 o
n
 Septem
ber 21, 2018 by guest
http://iai.asm
.org/
D
ow
nloaded from
 
To date, over 100 T4SS substrates have been identified in C.
burnetii using a variety of techniques, including bacterial-two-
hybrid (16), bioinformatics (16–19), plasmid localization (20,
21), and genomic (15) assays. Large-scale screening of these sub-
strates demonstrated that many traffic to distinct subcellular com-
partments, interfere with crucial host processes, and importantly,
are less functionally redundant than those of Legionella (15–18,
20–23). While phenotypes identified using these large-scale
screens aid in effector characterization, the biological function of
most of these substrates remains unknown. Three effector pro-
teins—CaeA, CaeB, and AnkG—were recently reported to play a
role in modulating host survival by interfering with apoptosis (6,
24), whereas a fourth effector, CvpA, was shown to engage the
clathrin-mediated transport pathway (17).
While these observations provide some insight into how C.
burnetii establishes its replicative niche, the molecular details of
how the spacious CCV is formed and maintained remains largely
unknown. In the present study, we identified a pathogen essential
T4SS effector, CirA, which stimulates RhoA GTPase activity to
promote vacuolar development. We show that in the absence of
CirA, C. burnetii resides in a tight-fitting vacuole that does not
expand, is attenuated in virulence, and is significantly impaired in
RhoA recruitment to the CCV. Collectively our results highlight
the importance of CirA in C. burnetii pathogenesis.
MATERIALS AND METHODS
Bacteria and host cell lines. The bacteria and yeast strains used for this
study are listed in Table S1 in the supplemental material. C. burnetii Nine
Mile phase II (NMII) clone 4 (RSA439) was propagated in ACCM-2 un-
der microaerophilic conditions as previously described (11). When re-
quired, 350 g/ml kanamycin or 5 g/ml chloramphenicol was added.
HeLa (ATCC), HEK293T (ATCC), and J774A.1 (ATCC) cells were
cultured in Dulbecco’s modified Eagle’s medium (DMEM) with 10% fetal
bovine serum (FBS). All cell lines were maintained at 37°C with 5% CO2.
Complementation of the cirA::Tn mutant. The 1169P-Kanr cassette
was PCR amplified from pMiniTn7-Kan (12) and cloned into pKM244
(18) to generate pEVS101. The open reading frame (ORF) Cbu0041 (cirA)
was PCR amplified and cloned into the SalI/KpnI of pCMV-DYKD-
DDDK-C (Clontech) to generate a C-terminal fusion to Flag tag. The
resulting fusion protein was amplified and cloned into the SalI/SphI site to
generate pEVS101-CirA.
Axenically cultured RSA439 MK2 (cirA::Tn) cells (18) were washed
twice and resuspended in distilled water to approximately 1010/ml. Elec-
trocompetent bacteria were mixed with 2 g pEVS101-CirA and electro-
porated as previously described (11). After 7 days, individual colonies
were expanded in ACCM-2 and screened by Western blotting for expres-
sion of the Flag-tagged fusion.
To determine if plasmid complementation of RSA439 MK2 rescued
the observed growth defect, HeLa or J774A.1 cells were infected with a
multiplicity of infection (MOI) of 50, and genomic equivalents were iso-
lated at 1 day and 4 days postinfection and analyzed by quantitative PCR
as previously described (18). For immunofluorescence, HeLa cells were
infected in triplicate with an MOI of 50, and at 5 days postinfection, cells
were fixed with 4% formaldehyde for 10 min, and nuclei were visualized
with 1 Hoechst. Fluorescence images were acquired with a Nikon-A1
microscope using the 60 oil immersion object, and images were pro-
cessed using NIS-Elements software.
To determine if CirA is necessary for virulence, we employed a SCID
FIG 1 CirA is necessary for virulence. (A) Confocal images of HeLa cells infected at an MOI of 50 for 5 days with an intergenic Tn mutant (Ig0179-0180), the
cirA::Tn mutant, and the cirA::Tn complemented (comp) mutant. Images were captured with a Nikon A1 confocal microscope with at least 500 infected cells
observed per experiment. Data are representative of three independent experiments. (B) Replication of wild-type RSA439, the cirA::Tn mutant, and the
complemented mutant in HeLa cells infected with an MOI of 50. Genome equivalents (GE) were determined at 4 days using quantitative PCR. Data are
representative of three independent experiments. (C) Five C57BL/6 mice per group were i.p. infected, and at 14 days postinfection, spleens were harvested, and
bacterial burden was determined by quantitative PCR. (B) Statistical analyses were tabulated using Student’s t tests and generated a statistical difference of P
0.01 (*) for the cirA::Tn mutant compared to the complemented mutant. (C) Statistical analyses were tabulated using one-way ANOVA and generated a
statistically significant difference of P 0.0001 (***) compared to RSA439 or P 0.05 (*) compared to the CirA::Tn complemented mutant.
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mouse model of C. burnetii (NMII) infection. Five C57BL/6 SCID mice
(Harlan) per group were intraperitoneally (i.p.) infected with 106 cells of
wild-type RSA439, the cirA::Tn mutant, or the cirA::Tn complemented
mutant. Mice were observed for clinical signs of infection daily, and at 14
days postinfection, spleens were harvested and homogenized as previ-
ously described (25). Total DNA was isolated and purified using Roche
Genomic DNA kits, and genome equivalents were determined using
quantitative PCR (18). All experimental procedures with animals were
approved by the Texas A&M University Institutional Animal Care Use
Committee and carried out in approved facilities in accordance with uni-
versity and federal regulations.
Immunofluorescence. To assess localization of CirA, HeLa cells were
seeded in triplicate into 24-well glass bottom plates at 105/ml. Cells were
transfected with Lipofectamine following the manufacturer’s instruc-
tions. Twenty-four hours posttransfection for rounding experiments or
15 h posttransfection for colocalization studies, cells were fixed with 4%
formaldehyde for 10 min and permeabilized with 0.1% Triton X-100 for 5
min, and nuclei were visualized with 1Hoechst. To assess colocalization
with Rho GTPases and to monitor suppression of toxicity, cells were
cotransfected with enhanced green fluorescent protein (EGFP)-CirA and
RhoA, RhoA Q63L, RhoA T19N, or Rac1 (see Table S2 in the supplemen-
tal material) and stained with anti-myc antibody (Thermo) and Alexa
Fluor 555 secondary antibodies (Cell Signaling). Actin was visualized us-
ing Alexa Fluor 555- or Alexa Fluor 647-conjugated phalloidin (Life Tech-
nologies). Cells possessing at least two filaments coursing through the
cytosol were considered positive for stress fibers, whereas cells possessing
less than two were considered negative for stress fibers. Results were tab-
ulated from triplicate wells with at least 50 cotransfected cells per experi-
ment. Similar results were obtained from at least three independent ex-
periments. For RhoA recruitment experiments, the RhoA pixel intensity
by the CCV (within 2M) was calculated using Nikon Elements software.
Yeast suppressor screen to identify host proteins capable of sup-
pressing CirA toxicity. cirA was introduced into pYesNTA2 as BamHI/
SalI fragments, and toxicity was assessed by serial dilution and spotting on
uracil dropout medium containing galactose as the sole carbon source
(18). The pYEp13 genomic library (ATCC no. 37323) was introduced into
Saccharomyces cerevisiae W303(pGal::cirA), and the resulting transfor-
mants were plated on uracil leucine dropout medium containing galac-
tose as previously described (26). From a transformation yielding 2.0 
106 transformants, 53 potential suppressors were isolated. To verify sup-
pression, plasmids were isolated and retransformed into S. cerevisiae
W303(pGal::cirA). Of these, 11 (pSup1 to pSup11) consistently sup-
pressed the toxicity of CirA. Suppressor plasmids were sequenced using
pYEp13 seq F (ACTACGCGATCATGGCGA) and pYEp13 seq R (TGAT
GCCGGCCACGATGC), and the results were analyzed using the yeast
genome database (http://yeastgenome.org).
Individual ORFs from the plasmids that consistently suppressed tox-
icity (pSup1 to pSup7) were introduced into p415ADH (27) as BamHI/
SalI or PstI/SmaI fragments. Individual plasmids were transformed into
W303(pGal::cirA), and the resulting transformants were serially diluted
and spotted on uracil leucine dropout medium.
GTPase assay. GTPase assays were performed as previously described
(28). His-tagged RhoA and Rac1 were purchased from Cytoskeleton, Inc.,
and preloaded with 10 mCi of [-32P]GTP. His-tagged CirA or His-tagged
FIG 2 Overexpression of CirA in mammalian cells leads to disruption of the cytoskeleton. (A) HeLa cells were transiently transfected with EGFP-CirA or EGFP,
and stress fibers were visualized by staining with Alexa Fluor 555-phalloidin. Scale bars in merged images are 10 m. (B and C) Rounding and stress fiber
disruption were assessed 24 h posttransfection by counting at least 150 transfected cells. Data are representative of three independent experiments. Statistical
analyses were tabulated using Student’s t test and generated a statistically significant difference of P 0.0001 (***) for EGFP-CirA compared to EGFP alone.
Weber et al.
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vector was purified from yeast as previously described (26). Preloaded
Rho GTPase was mixed with His-tagged CirA, His-tagged vector, or His-
tagged Rho GTPas-activating protein (GAP) as a positive control. At
5-min intervals, aliquots were removed and filtered through nitrocellu-
lose filters. Filters were washed and dried, and the amount of radioactive
nucleotide remaining was determined by scintillation counting.
Uptake assay. To rule out differences in uptake between the strains,
bacteria were stained with carboxyfluorescein succinimidyl ester (CFSE)
following the manufacturer’s guidelines (Life Technologies). Bacteria
were enumerated as previously described (18), and an MOI of 10 was used
to infect J774A.1 macrophages seeded at 105/ml in glass bottom 24-well
dishes. Four hours postinfection, cells were washed 3 times with phos-
phate-buffered saline (PBS), and extracellular fluorescence was quenched
using trypan blue. Cells were counted using a Nikon-A1 microscope using
the 60 oil immersion objective lens. At least 200 cells were counted per
well, with at least three wells per experiment. Similar results were obtained
from at least three independent experiments. The percentage of infection
was tabulated by counting the number of infected cells compared with the
total number of cells.
Data analysis. For statistical analysis, data were analyzed using one-
way analysis of variance (ANOVA) or with Student’s t test and generated
a minimum threshold of significance of P 0.05. When required, Dun-
nett’s test was used as a posttest to compare all samples to the control. All
statistical analyses were conducted using GraphPad Prism.
RESULTS
CirA is necessary for virulence. We previously reported the iden-
tification of more than 80 T4SS substrates (16, 18), of which mu-
tants with mutations in 10 of them exhibited an intracellular
growth defect (18). Coinfection with wild-type bacteria rescued
the growth defect for five of these transposon mutants, suggesting
that the observed growth defect is due to the loss of the individual
effector proteins, which we designated Coxiella effector for intra-
cellular replication (CirA to -E).
To further substantiate that the observed growth defect is due
to the loss of CirA, we complemented RSA439 MK2 (cirA::Tn)
(18). As previously reported, cirA::Tn had a phenotype compara-
ble to that of a Dot/Icm mutant and did not replicate in HeLa or
J774A.1 cells (18). Plasmid complementation of cirA::Tn with an
inducible N-terminally FLAG-tagged CirA resulted in visible for-
mation of a spacious vacuole comparable to that in an intergenic
control (Fig. 1A). Growth comparison, as determined by genome
equivalents, demonstrated that the cirA::Tn mutant was signifi-
cantly impaired in intracellular replication, a defect that was par-
tially rescued by complementation with Flag-CirA (Fig. 1B). The
partial complementation was not unexpected as overexpression of
an inducible CirA would circumvent the spatial temporal regula-
tion of this effector. Together, these results indicate that the T4SS
effector CirA is needed for intracellular replication and CCV for-
mation.
To determine if CirA is necessary for virulence, we utilized a
SCID mouse model of C. burnetii infection. In line with previous
studies (25), mice infected with wild-type RSA439 exhibited a
high bacterial burden in the spleen. In contrast, mice infected with
the cirA::Tn mutant exhibited a significantly reduced splenic bac-
terial burden (Fig. 1C), which was not statistically different from
infection with the icmX::Tn mutant, a Dot/Icm secretion system
mutant previously established as necessary for replication in cell
culture (18). Complementation of the cirA::Tn mutant resulted in
a significantly higher bacterial burden in the spleen compared to
both the cirA::Tn and icmX::Tn mutants. Of note, CirA is the first
C. burnetiiT4SS substrate to be shown to be essential for virulence
in an animal model. Furthermore, our results show for the first
time that the Dot/Icm secretion system is required for virulence.
Collectively these results establish CirA as a key C. burnetii viru-
lence factor and validate the SCID mouse model as a crucial tool
for screening C. burnetii transposon mutants.
Overexpression of CirA leads to cell rounding and disrup-
tion of stress fibers. To develop a mechanistic model for CirA’s
role in disease, HeLa cells were transfected with EGFP-CirA. At
15 h posttransfection, CirA predominately localized to the plasma
membrane with small puncta distributed throughout the cyto-
plasm and in close proximity to the membrane. In contrast, cells
expressing EGFP alone exhibited a uniform localization through-
out the cell. Further characterization of CirA overexpression in
either Hek293 or HeLa cells at later time points (15 to 24 h post-
transfection) (Fig. 2A) resulted in a dramatic phenotype charac-
terized by rapid cell rounding, membrane blebbing, decreased
puncta, and detachment from the culture dish (see Movie S1 in the
supplemental material). By 24 h posttransfection, 77% of CirA-
expressing cells had rounded and detached, whereas only 13% of
cells transfected with the negative control (EGFP alone) had
rounded, and these cells did not show signs of membrane blebbing
or detachment (Fig. 2B; see Movie S2 in the supplemental mate-
rial). Phalloidin staining revealed that cells transfected with CirA
did not exhibit the robust stress fiber formation seen in cells trans-
fected with EGFP alone (Fig. 2C). Only 24% of cells transfected
with EGFP-CirA possessed stress fibers, whereas 85% of EGFP-
transfected cells exhibited robust stress fiber formation. Collec-
FIG 3 Overexpression of Rho1 suppresses the toxicity of CirA in yeast. (A) S.
cerevisiae W303, overexpressing CirA from a galactose-inducible promoter,
was transformed with the yeast genomic library pYEp13. Eleven clones (pSup1
to pSup11) were isolated that consistently suppressed the toxicity of CirA. (B)
Yeast orf genes present in pSup1 to pSup7. (C) Individual expression of the
full-length orf genes in pSup1 revealed that Rho1 is capable of suppressing
CirA toxicity. Data are representative of at least three independent experi-
ments.
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tively these results suggest that overexpression of CirA perturbs
the actin cytoskeleton of the host cell.
CirA targets the Rho GTPase RhoA. We previously reported
that CirA was toxic when heterologously expressed in yeast (18).
To identify the host proteins targeted by CirA, we conducted a
yeast suppressor screen to identify proteins that, when overex-
pressed, were capable of suppressing CirA toxicity. An S. cerevisiae
strain expressing CirA from a galactose-inducible promoter was
transformed with the pYEp13 yeast genomic library (26). From a
transformation yielding 2.0 106 transformants, 53 colonies were
isolated, 11 (pSup1 to pSup11) of which consistently suppressed
the toxicity of CirA (Fig. 3A). Sequencing revealed over half of
these clones contained identical plasmids (pSup1 to pSup7), car-
rying five full-length yeast orf genes and a truncated mms1 gene
(Fig. 3A and B). Individual expression of each full-length orf gene
revealed that only the small GTPase Rho1 was capable of suppress-
ing CirA toxicity, suggesting that Rho1 is a cellular target of CirA
(Fig. 3C).
To assert that our observations in yeast are predictive of mam-
malian targets, we cotransfected HeLa cells with EGFP-CirA and
the mammalian Rho GTPase RhoA (mammalian homology of
Rho1) or Rac1. As shown in Fig. 4A to C, coexpression of CirA
with RhoA, but not Rac1, rescued stress fiber formation and in-
hibited rounding to levels comparable to those in EGFP-trans-
fected cells. Furthermore, the Rho GTPase RhoA, but not Rac1,
colocalized with CirA (Fig. 5). No colocalization between EGFP
and any of the GTPases was noted. These results further support
that CirA interacts with the Rho GTPase RhoA.
To establish whether suppression of cell rounding and disrup-
tion of stress fibers requires a specific activation state of the Rho
GTPase, we cotransfected cells with a GTP-locked (Q63L) or
GDP-locked (T19N) RhoA. Cotransfected cells overexpressing a
GTP-locked RhoA exhibited reduced cell rounding and robust
stress fiber formation compared with CirA alone or cells cotrans-
fected with a GDP-locked RhoA (Fig. 4B and C). The finding that
suppression of CirA induced cell rounding and stress fiber disrup-
tion requires the GTP-bound form of RhoA suggests that CirA
inhibits Rho signaling by inactivating Rho GTPases.
CirA stimulates RhoA GTPase activity. To establish if CirA is
able to stimulate RhoA, we employed a GTPase assay. His-tagged
CirA, purified from yeast, was incubated with recombinant His-
tagged RhoA or Rac1 preloaded with [-32P]GTP. Aliquots were
removed at 5-min intervals over 15 min, and the amount of pro-
tein bound radioactive nucleotide captured by the filter was mea-
sured by scintillation counting. As shown in Fig. 6, His-tagged
CirA robustly stimulated the GTPase activity of RhoA similar to
the p50 subunit of the Rho GAP-positive control. No activity was
detected with Rac1 or when any of the Rho GTPases were incu-
bated with purified His-tagged protein expressed by vector alone
from yeast. These results indicate that CirA can stimulate RhoA
GTPase activity.
CirA is dispensable for uptake. Several pathogenic bacteria
secrete effector proteins or toxins that target Rho GTPases to
modulate uptake (29, 30). However, the T4SS of C. burnetii may
not be active until at least 8 h postinfection and requires CCV
acidification and endocytic maturation (31) for appropriate func-
FIG 4 Overexpression of RhoA in mammalian cells rescues cell rounding and stress fiber formation. (A to C) HeLa cells were cotransfected with EGFP-CirA or
GFP alone or myc-tagged RhoA or Rac1, and stress fibers were visualized by staining with Alexa Fluor 647-conjugated phalloidin. Scale bars in merged images
are 10 m. (B and C) To determine if the GTPase state of Rho is necessary for suppression of CirA toxicity, cells were cotransfected with constitutively active
(Q63L) or dominant-negative (T19N) RhoA. Rounding and stress fiber disruption were determined 24 h posttransfection by counting at least 50 transfected cells
from triplicate wells. Data are representative of at least three independent experiments. Statistical analyses were tabulated using one-way ANOVA and generated
a statistically significant difference of P 0.0001 (***) or P 0.05 (**) compared to EGFP alone.
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tion. This observation theoretically precludes T4SS substrates
from playing a role in bacterial uptake or initial stages of endocytic
trafficking. We speculate that it is therefore highly unlikely that
CirA interacts with Rho GTPases to modulate bacterial uptake. To
test this hypothesis, we compared uptake of CFSE-labeled bacteria
by J774Al.1 macrophages. As predicted, uptake was not im-
pacted by CirA mutation and was only impaired for the pre-
dicted enhC::Tn positive control, a protein homolog previously
established to be involved in Legionella uptake (Fig. 7) (32). This
observation strongly indicates that CirA does not engage RhoA to
modulate bacterial uptake.
Rho GTPase recruitment to the CCV requires CirA. In addi-
tion to regulating cytoskeletal rearrangements, Rho GTPases play
an integral role in regulating vesicle trafficking through endoplas-
mic reticulum to the Golgi compartment and endocytic and exo-
cytic transport pathways (33). Importantly, RhoA but not Rac1 is
recruited to the CCV and plays an integral role in CCV formation
(34). Immunofluorescence analysis of infected HeLa cells revealed
that CCVs harboring mutant cirA::Tn bacteria were significantly
impaired in their ability to recruit RhoA relative to cells infected
with intergenic or cirA::Tn complemented strains (Fig. 8), sug-
gesting that CirA modulates Rho GTPases to promote CCV mat-
uration. We repeated these localization studies with antibody rec-
ognizing native RhoA to eliminate potential artifacts inherent in
overexpressed, transiently transfected cells. An example of RhoA
localization during infection by the wild type is shown in Fig. S3 in
the supplemental material.
DISCUSSION
We previously demonstrated that the T4SS effector CirA is essen-
tial for intracellular replication and CCV formation (18). CirA is
highly conserved among C. burnetii pathotypes, suggesting that it
may be essential for establishment of this obligate intracellular
pathogen niche. In the present study, we sought to characterize the
role of CirA in pathogenesis. To do so, we employed a yeast sup-
pressor screen to identify host proteins targeted by CirA. We
found that CirA is highly toxic in yeast and causes cytopathic
effects (stress fiber disruption and rounding) in mammalian cells,
and these effects can be suppressed by overexpression of the Rho
GTPase RhoA. This suppression requires the GTP-bound state of
the GTPase, suggesting that the function of CirA is to interfere
with cellular RhoA signaling. Biochemical assays indicate CirA
FIG 5 Ectopically expressed EGFP-CirA colocalizes with Rho GTPases RhoA but not Rac1. Representative micrographs of HeLa cells cotransfected with
EGFP-CirA or EGFP (green) and myc-tagged RhoA or Rac1 (red). White boxes denote the areas shown in the insets. Scale bars in merged images are 10m. Data
are representative of three independent experiments with at least 100 cotransfected cells per experiment.
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stimulates RhoA GTPase activity. Importantly, we identified CirA
as the first C. burnetii T4SS effector protein essential for growth
and pathogenesis in an animal model.
Saccharomyces cerevisiae has emerged as a valuable model to
characterize bacterial virulence factors due to the conservation of
many pathways between yeast and mammals, genetic tractability,
and ease of use (35). Heterologous expression of bacterial effector
proteins in yeast has been exploited in numerous studies to iden-
tify effectors that impair crucial host processes (15, 18, 26, 36, 37).
In an attempt to understand the function of these toxic effectors,
yeast genetic screens have been employed to identify host proteins
that, when overexpressed, suppress the toxicity of the effector pro-
tein (26, 38, 39). One key study showed that the lethality associ-
ated with L. pneumophilaAnkX was suppressed by overexpression
of components involved in membrane trafficking, which allowed
the investigators to determine that AnkX modifies Rab1 by phos-
phorylcholination (26). This screening tool has since been ex-
tended to characterize two other effectors: LecE, an effector that
manipulates phospholipid biosynthesis (39), and Ceg14, an effec-
tor that inhibits actin polymerization (38).
Based on the successful application of the yeast suppressor
screens for the characterization of Legionella effectors, we chose
to employ this tool as a means to identify the host pathways
targeted by CirA. Using this approach, we demonstrated that
the toxicity of CirA could be suppressed by overexpression of
the Rho GTPase Rho1, suggesting this is the pathway targeted by
CirA. Rho GTPases are targeted by many bacterial effector pro-
teins, including Yersinia pseudotuberculosis YopE (30), Salmonella
enterica serovar Typhimurium SopE (40), Vibrio cholerae RTX
toxin (41), and Escherichia coli EspH (29), indicating this is a con-
served target of bacterial pathogens (42). Bacterial virulence fac-
tors and toxins regulate Rho activity using at least one of three
methods (42): (i) through indirect regulation of localization and
activation by mimicking Rho GAPs, guanine nucleotide exchange
factors (GEFs), or guanine nucleotide dissociation inhibitors
(GDIs) (30, 43); (ii) direct regulation through posttranslational
FIG 6 CirA stimulates RhoA GTPase activity on RhoA. Activity of His-tagged
CirA or His-tagged vector toward RhoA or Rac1 was determined using a
GTPase assay. Data are representative of three independent experiments.
FIG 7 CirA is dispensable for bacterial uptake. J774A.1 macrophages were
infected with CFSE-labeled bacteria for 4 h at an MOI of 10. Only the enhC::Tn
positive control was deficient in uptake. Data are representative of three inde-
pendent experiments with at least 600 cells compared from triplicate samples.
Statistical analysis were tabulated using one-way ANOVA and generated a
statistically significant difference of P 0.0001 (***).
FIG 8 RhoA recruitment to the CCV requires CirA. HeLa cells, infected with
an MOI of 100 for 48 h, were transfected with myc-tagged RhoA. Data are
representative of two independent experiments with at least 100 infected trans-
fected cells per well and three wells per experiment. RhoA recruitment was
quantitated as described in Materials and Methods. Scale bars are 5m. White
boxes denote the areas shown in the insets. Statistical analyses were tabulated
using one-way ANOVA and generated a statistically significant difference of
P  0.0001 (***) compared to Ig0179-180 or P  0.01 (**) compared to the
cirA::Tn complemented mutant (Comp).
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modifications, including ADP-ribosylation (44), adenylation
(45), deamidation (46), and glucosylation (47); (iii) or through
targeting upstream regulators (29, 48). Consequently these mod-
ifications affect Rho GTPase activity and ultimately impact host
signaling pathways, resulting in inhibition of immune function or
endocytosis, generating a more permissive host for the pathogen.
Many pathogenic bacteria target cytoskeletal components, in-
cluding actin, intermediate filaments, and microtubules, and to
modulate invasion, establish a replicative niche, and facilitate cell-
to-cell spread through actin-based motility, as well as for dissem-
ination (49–51). Specifically, several pathogens secrete T3S effec-
tors that target Rho GTPases to modulate uptake. Salmonella
releases at least four effector proteins to modulate actin rearrange-
ments through Rho GTPases: SopE and SopE2 directly activate
GTPases by mimicking Rho GEFs (52, 53), whereas SopB indi-
rectly activates Rho GTPases through its interaction with inositol
phosphatase (54). Following actin polymerization, SptP down-
regulates cytoskeletal rearrangements induced by other type III
secretion (T3S) effectors by acting as a Rac1 and Cdc42 GAP. This
tightly balanced cycle acts to rebuild the cytoskeleton following
invasion (40). In contrast to the model exemplified by Salmonella,
Yersinia secretes an array of antiphagocytic T3S effectors that dis-
rupts the cytoskeleton to block uptake: most notable is YopE,
which targets RhoA, Rac1, and Cdc42 by mimicking Rho GAPs
(30). While targeting of Rho GTPases to modulate uptake is a
common theme among secreted effectors, C. burnetii CirA
uniquely targets Rho GTPases post-uptake. Our results suggest
that CirA may be involved in formation of the spacious CCV as
both F-actin and Rho GTPases are recruited to the CCV and are
crucial for normal development (34). F-actin assembles on phago-
somes, which serves as a delivery network on which lysosomes or
late endosomes can progress to ultimately fuse with phagosomes
(34, 55). This suggests that recruitment of Rho GTPases may fa-
cilitate heterotypic fusions with endosomes and lysosomes as well
as homotypic fusions with other small CCVs and may serve as a
method for delivering membrane to the growing vacuole (34).
Regulation of numerous cell processes, including vesicle traf-
ficking, phagocytosis, cell motility, and cell adhesion, requires
rapid remodeling of the actin cytoskeleton (33, 56). These pro-
cesses are tightly controlled and regulated by numerous signaling
molecules, including Rho GTPases, which provide directionality
for trafficking of cargo on actin tracks. In yeast, Golgi compart-
ment-derived vesicles are directed toward the emerging bud
through dramatic reorganization of the actin cytoskeleton (57).
This redirection of vesicle trafficking requires trafficking of both
the GTPase and its cognate regulators in the vesicle to the desig-
nated target site. For instance, the Rho GAP bud emergence pro-
tein 3 (bem3) from yeast resides in recycling endosomes and ac-
tively facilitates delivery of secretory vesicles to the bud tip. While
the exact mechanism for bem3 activity is unclear, it highlights the
involvement of Rho GTPases in vesicle trafficking. In animal cells,
Rho GTPases not only associate with the plasma membrane but
also localize to numerous intracellular compartments where they
regulate endosome recycling, clathrin-dependent and -indepen-
dent endocytosis, and Golgi compartment-to-ER transport. How
Rho GTPases control membrane trafficking is ill defined; how-
ever, actin reorganization appears to be crucial (58).
Collectively, our results support a model in which CirA is es-
sential for pathogenesis and the formation of the CCV and targets
RhoA. The localization of ectopically expressed CirA to the plasma
membrane suggests that CirA may reside on the CCV during in-
fection. Our data suggest that CirA may engage RhoA on the CCV
and stimulate its GTPase activity. The toxic nature of CirA when
ectopically expressed in yeast and the cytopathic effects in mam-
malian cells suggest that regulation of this effector is tightly con-
trolled, as C. burnetii is described as a stealth pathogen invading
and replicating undetected by the host cells. The importance of
spatiotemporal regulation of toxic effectors has been highlighted
byusing an example in L. pneumophilawhere the toxicity of SidE is
suppressed by another effector SidJ (59). It is likely that functions
of CirA are tightly controlled during C. burnetii infection to pre-
vent the toxic effects seen when this effector is overexpressed. The
spatiotemporal regulation of CirA and the consequences during
infection are under investigation.
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